"Metabolic disease" is an umbrella term for a group of related conditions that share common biological drivers — most notably insulin resistance, chronic inflammation, and dysfunctional energy regulation. Understanding metabolic disease as a continuum helps explain why obesity, prediabetes, Type 2 diabetes, and fatty liver disease so often appear together.
The metabolic disease continuum
- Insulin resistance — cells respond less efficiently to insulin.
- Prediabetes — blood glucose is elevated but below the diabetes threshold.
- Type 2 diabetes — sustained hyperglycemia and beta-cell stress.
- MASLD / fatty liver disease — excess fat in liver tissue.
- Cardiovascular disease — the most common long-term consequence.
Why it matters
Treating one condition in isolation often misses the upstream driver. A metabolic approach asks: what is happening to insulin signaling, body composition, appetite hormones (GLP-1, ghrelin, leptin), and liver function — and how do treatment options affect the whole system?
What helps
Evidence-based options include lifestyle interventions, pharmacotherapy (including GLP-1 receptor agonists), endoscopic interventions, and metabolic surgery. The right pathway depends on disease severity, comorbidities, prior treatments, and individual goals.